Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination

P Kaul1, L K Newby, Y Fu

  • 1University of Alberta, Edmonton, Alberta, Canada. pkaul@ualberta.ca

Insights

Revascularisation improves survival in non-ST elevation acute coronary syndromes with ST depression. However, procedure use varies internationally and is insensitive to ST depression extent, indicating care delivery inefficiencies.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Non-ST elevation acute coronary syndromes (NSTE-ACS) represent a significant cause of cardiovascular mortality.
  • Baseline electrocardiogram (ECG) findings, such as ST segment depression, can stratify risk in NSTE-ACS patients.
  • The role of revascularisation in NSTE-ACS based on ECG findings requires further investigation.

Purpose of the Study:

  • To investigate the relationship between baseline ST segment depression and outcomes after revascularisation in NSTE-ACS.
  • To determine if ST segment depression influences clinical decision-making regarding cardiac procedures.
  • To assess international variations in cardiac procedure utilization across different levels of ST segment depression.

Main Methods:

  • Analysis of 11,453 patients from GUSTO-IIB, PARAGON-A, and PARAGON-B trials.
  • Patients categorized by ST segment depression severity: none, ≥1 mm (two contiguous leads), and ≥2 mm (two contiguous leads).
  • Comparison of revascularisation rates and outcomes across four geographic regions (USA, Canada, Europe, Australia/New Zealand).

Main Results:

  • Revascularisation showed no survival benefit in patients without ST depression.
  • A significant survival benefit was observed with revascularisation in patients with ST depression ≥1 mm.
  • An inverse relationship existed between ST depression extent and the use of angiography/angioplasty, though bypass surgery increased with greater ST depression.
  • Only the USA demonstrated a trend of increased revascularisation with increasing ST depression.

Conclusions:

  • Current international practice patterns for cardiac procedures in NSTE-ACS appear inadequately sensitive to the extent of ST segment depression.
  • Significant opportunities exist to optimize the delivery of care and improve patient outcomes across all studied regions.
  • Standardizing care based on objective ECG markers like ST depression could enhance treatment efficiency.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...